Online decision aid for prostate cancer screening
Evaluation of an Online Prostate Cancer Screening Decision Aid
NA · Centers for Disease Control and Prevention · NCT06610474
This study tests whether an online tool called 'Talk to Nathan About Prostate Cancer Screening' can help men make better choices about prostate cancer screening compared to standard resources.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 900 (estimated) |
| Ages | 55 Years to 69 Years |
| Sex | Male |
| Sponsor | Centers for Disease Control and Prevention (fed) |
| Locations | 2 sites (E. Northport, New York and 1 other locations) |
| Trial ID | NCT06610474 on ClinicalTrials.gov |
What this trial studies
This clinical trial evaluates the effectiveness of an online decision aid called 'Talk to Nathan About Prostate Cancer Screening' in helping men make informed decisions about prostate cancer screening. The study compares this decision aid to a standard decision aid and standard educational materials to assess improvements in knowledge, health literacy, and decisional conflict. Participants will complete surveys before and after using the decision aids, and healthcare providers will also provide feedback on the integration of the tool into primary care. The goal is to enhance decision-making aligned with individual patient values and preferences.
Who should consider this trial
Good fit: Ideal candidates are males aged 55-69 who are scheduled for a health exam and have internet access.
Not a fit: Patients with a prior history of prostate cancer or current urinary tract symptoms may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could empower patients with better knowledge and confidence in making informed decisions about prostate cancer screening.
How similar studies have performed: Other studies have shown promise in using decision aids for cancer screening, suggesting that this approach could be effective.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Male. * Aged 55-69 years. * Scheduled for an upcoming health exam. * Has access to the internet. * Has a valid email address or valid mobile phone number with SMS capabilities. * Speaks and reads English or Spanish. Exclusion Criteria: * Refuses to participate. * Currently has urinary tract symptoms (i.e., difficulty starting urination; weak or interrupted flow of urine; urinating often, especially at night; trouble emptying the bladder completely; pain or burning during urination; blood in the urine or semen; pain in the back, hips, or pelvis that doesn't go away; or painful ejaculation). * Prior history of prostate cancer. * Scheduled for, undergoing, or has had a prostate biopsy. * A previous PSA score is contained in the patient's health record and it is \> 3 ng/mL and/or a very suspicious digital rectal exam (DRE) result (defined as the presence of significant induration, nodularity, or asymmetry). * Patient has a terminal illness, significant psychiatric comorbidity (identified by clinic coordinator), cognitive deficits, or reports of ongoing substance misuse.
Where this trial is running
E. Northport, New York and 1 other locations
- East Northport Medical Care — E. Northport, New York, United States (RECRUITING)
- Alliance Medical Ministry — Raleigh, North Carolina, United States (RECRUITING)
Study contacts
- Study coordinator: Nancy Sacco, PhD
- Email: nancy.sacco@sitebridgeresearch.com
- Phone: 847-345-3931
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Prostate Cancer, Decision Aid